Obesity and Mindful Eating in Patients With Anxiety (OMETA)
Anxiety, Obesity, Eating Behavior
About this trial
This is an interventional treatment trial for Anxiety focused on measuring Anxiety, Obesity, Eating Behavior, Mindfulness
Eligibility Criteria
Inclusion Criteria: Be between 18 and 50 years old; Inclusion for Generalized Anxiety Disorder (GAD): Primary GAD diagnosed by the M.I.N.I.; ✔Inclusion for Obesity: Obesity BMI grade I (between 30.0 and 34.9); Obesity BMI grade II (between 35.0 and 39.9) Exclusion Criteria: In individuals with obesity or control only, not having any psychiatric disorder; In individuals with only GAD or control, do not have a BMI above 25. In individuals with GAD, not having a diagnosis of primary or severe depression; Being under psychopharmacological, psychotherapeutic or nutritional treatment; Bipolar Disorder, Psychotic Disorder, Substance Use Disorder (except Tobacco) in the last 6 months or Suicidal Ideation in the last 6 months (M.I.N.I); Have a clinical instability or immobility; Being in Pregnancy or Lactation; Antisocial Personality Disorder; Eating Disorder.
Sites / Locations
- Hospital de Clínicas de Porto AlegreRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Mindful Eating Group
Video Group
Mindful Eating practices will be taught during a weekly meeting lasting 150 minutes and individuals will be encouraged to integrate the practices learned into their daily lives, for at least 15 minutes a day, being progressively integrated into the other practices that will be taught in subsequent weeks. There will be a WhatsApp group with reminders during the week and audio for guided practice.
Composed of 5 videos sent weekly produced by trained professionals. The topics discussed will be relevant to the management of anxiety in general and lifestyle changes. Video 1: Psychoeducation of anxiety. Video 2: Healthy eating. Video 3: Sleep hygiene. Video 4: Physical activity. Video 5: Substance use. This protocol used as a control was effective as a Psychoeducation Group in improving anxiety symptoms in patients with generalized anxiety disorder.